SARS-CoV-2

scroll for more
  • The billion dose challenge: manufacturing of a new vaccine on a pandemic scale

    The billion dose challenge

    As SARS-CoV-2 spreads around the world, pandemic preparedness is a key topic discussed. Despite increasing efficiency and speed of drug discovery, as well accelerated tracks to regulatory approval, one essential question remains: Is the industry prepared to meet the challenges of immediate and large-scale manufacturing of a novel vaccine to guarantee widespread and cost-efficient availability?

    Read more
Do NOT follow this link or you will be banned from the site!